SPHK2 and plasma cell myeloma: Moreover, specific pharmacological inhibition of SphK2 inhibited myeloma tumor growth in vivo in a mouse xenograft model using the MM.1S human myeloma cell line injected via tail vein or subcutaneously into sublethally irradiated NSG mice (164).